QUÉBEC CITY, Aug. 4
/PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX:
AEZ) (the "Company"), a late-stage drug development company
specialized in oncology and endocrinology, will announce its second
quarter 2010 financial and operating results before market open on
Thursday, August 12, 2010. The
Company will host a conference call and webcast to discuss these
results later that same day at 1:30 p.m.,
Eastern Time.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Investors" section, or by
telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7451, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a late-stage drug development company
specialized in oncology and endocrinology. News releases and
additional information are available at www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.
Copyright g. 4 PR Newswire